The KPNA5 Knockout HT29 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population targeting the KPNA5 gene in the HT29 colorectal adenocarcinoma cell line. This product provides a loss-of-function model for studying importin subunit alpha-5, a critical adaptor protein in the classical nuclear import pathway. The polyclonal knockout pool enables robust analysis of gene function without the clonal selection bias inherent to monoclonal cell lines, making it suitable for population-level studies of nucleocytoplasmic transport in cancer biology.
The HT29 cell line, derived from a human colorectal adenocarcinoma, is a well-established adherent epithelial model widely used in colorectal cancer research. These cells retain key characteristics of intestinal epithelial cells and are commonly employed to investigate oncogenic signaling, cell cycle regulation, and drug responses. The HT29 background provides a clinically relevant context for examining the consequences of impaired nuclear transport on colorectal tumor cell biology.
KPNA5 encodes importin alpha-5, which specifically recognizes proteins bearing classical nuclear localization signals (cNLS). Mechanistically, KPNA5 acts as an adaptor, bridging cNLS-containing cargo proteins with importin beta-1 (KPNB1) to form a trimeric import complex. This complex docks at the nuclear pore complex via interactions with nucleoporins and is translocated into the nucleus. Nuclear import is terminated by RanGTP binding to KPNB1, releasing the cargo. Key cargoes include transcription factors and cell cycle regulators such as cyclins and cyclin-dependent kinases, placing KPNA5 at the nexus of signal transduction and cell cycle control.
In the context of colorectal cancer, aberrant nucleocytoplasmic trafficking contributes to altered localization of tumor suppressors and oncogenic transcription factors, impacting proliferation, apoptosis, and therapeutic resistance. By disrupting KPNA5 expression, this polyclonal knockout model enables investigation into how dysregulated nuclear import influences colorectal cancer cell behavior. Researchers can assess the effects on downstream pathways reliant on NLS-mediated import, such as transcriptional programs controlling cell fate and response to genotoxic stress.
Typical applications include western blotting and immunofluorescence to verify loss of KPNA5 and monitor nucleocytoplasmic distribution of known cargo proteins. Functional assays such as cell proliferation, apoptosis, and colony formation can quantify the phenotypic impact of KPNA5 disruption. Additionally, RNA sequencing and drug sensitivity testing with importin inhibitors (e.g., ivermectin or Karyopherin-targeted compounds) can elucidate transcriptomic changes and therapeutic vulnerabilities. Co-immunoprecipitation experiments further enable mapping altered protein interactions within the importin network. For inquiries regarding this product, please contact Ascent Research.
